These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 409419)

  • 41. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
    Marighetto A; Valerio S; Philippin JN; Bertaina-Anglade V; Drieu la Rochelle C; Jaffard R; Morain P
    J Psychopharmacol; 2008 Jul; 22(5):511-21. PubMed ID: 18308794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine-agonist drugs and cerebral electrical activity in the rabbit.
    Savoldi F; Tartara A; Bo P
    Farmaco Sci; 1979 Jun; 34(6):526-34. PubMed ID: 572783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weight change during various neuropharmacologic manipulations in psychotic inpatients.
    Carman JS; Wyatt RJ; Nasrallah HA; O'Brien P; Gillin JC
    Acta Cient Venez; 1978; 29(3):178-80. PubMed ID: 757726
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst.
    Dourish CT; Cooper SJ
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():19-23. PubMed ID: 689849
    [No Abstract]   [Full Text] [Related]  

  • 45. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The search for compounds with dopaminergic action. V. Synthesis of piribedil analogs].
    Woliński J; Kujawa T
    Acta Pol Pharm; 1987; 44(2):143-6. PubMed ID: 2893511
    [No Abstract]   [Full Text] [Related]  

  • 47. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 48. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
    [No Abstract]   [Full Text] [Related]  

  • 49. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
    Carruba MO; Ricciardi S; Mantegazza P
    Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Ludin HP; Kunz F; Lörincz P; Ringwald E
    Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
    [No Abstract]   [Full Text] [Related]  

  • 52. Dopaminergic agonists in the treatment of Parkinson's disease.
    Goetz CG; Diederich NJ
    Neurol Clin; 1992 May; 10(2):527-40. PubMed ID: 1350052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New perspectives in the treatment of Parkinson's disease.
    LeWitt PA
    Clin Neuropharmacol; 1986; 9 Suppl 1():S37-54. PubMed ID: 3085929
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results].
    Oules MJ; Boscredon J
    Ann Med Psychol (Paris); 1979 Nov; 137(9):921-5. PubMed ID: 547794
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of refractory OCD with the dopamine agonist bromocriptine.
    Ceccherini-Nelli A; Guazzelli M
    J Clin Psychiatry; 1994 Sep; 55(9):415-6. PubMed ID: 7929024
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of dopaminergic drugs (pyridoxine, 2-bromo-alpha-ergocriptine, piribedil) in blocking lactation].
    Lo Dico G; Milia S; Firinu C; Pes F; Masala A; Alagna S; Stoppelli I
    Minerva Ginecol; 1980 Sep; 32(9):771-9. PubMed ID: 7219829
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of dopaminergic agonists on genital reflexes in paradoxical sleep-deprived male rats.
    Andersen ML; Tufik S
    Physiol Behav; 2005 Feb; 84(2):205-10. PubMed ID: 15708772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term clinical and electrophysiological study of a new dopaminergic agonist in 54 patients with parkinsonism].
    Truelle JL; Chanelet J; Bastard J; Six P; Emile J
    Sem Hop Ther; 1977 Nov; 53(9):453-6. PubMed ID: 341320
    [No Abstract]   [Full Text] [Related]  

  • 60. Modification of involuntary movements by centrally acting drugs.
    Goldstein M; Battista AF; Miyamoto T
    Adv Neurol; 1975; 9():299-305. PubMed ID: 167567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.